Tetratherix, a medical device company backed by Xero founder Rod Drury, is set to float on the ASX this month, raising $25 million with an ambitious pitch to investors about the potential of its “medical Lego” product that helps the human body heal faster from injuries and surgery.
The company’s product has been in scientific development since 2011, and is built on the work of chief technical officer Ali Fathi, a biomolecular engineer who invented a new material that can be injected into wounds to help tissue and bones heal.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.